Ahmed Hamid, an assistant professor in Auburn University s Department of Chemistry and Biochemistry, is focused on research that one day could lead to greater detection of Alzheimer s disease, quicker analysis of bacterial infections and enhanced security checkpoints at airports.
The project, titled “Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer’s disease,” is funded by the National Institute of Neurological Disorders and Stroke Innovation Grants to Nurture Initial Translational Efforts program, or IGNITE.
The project, titled “Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer’s disease,” is funded by the National Institute of Neurological Disorders and Stroke Innovation Grants to Nurture Initial Translational Efforts program, or IGNITE.
The Harrison College of Pharmacy s Raj Amin has received $1.1 million in support from the National Institutes of Health for the development of a compound that could help certain individuals who may be more susceptible to Alzheimer s disease at an earlier age.